Venture Capital Investors

Xencor

Xencor is a VC investing group that helps tech entrepreneurs.

Venture Investor Overview

Contact Information

Background Information

Overview

Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045 and XmAb13676. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/8/2022

Transaction History

Our records indicate that Xencor invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Bassil Dahiyat

        

Chief Financial Officer

John Kuch

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Xencor has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

xdeck | Xenia Ventures

Share this article

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary